Halozyme, Inovalon, and Teva Soared This Week: Can They Go Higher?
Many healthcare stocks muddled along over the past week. That wasn't the case, though, for three stocks of companies operating in very different parts of the healthcare spectrum.
Shares of Halozyme Therapeutics (NASDAQ: HALO), Inovalon Holdings (NASDAQ: INOV), and Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) jumped by at least 16% this week. Here's why the stocks soared, and a look at whether they can go even higher.
Image source: Getty Images.
Source: Fool.com
Bristol-Myers Squibb Stock
€46.46
11.400%
With 8 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 70 € shows a very positive potential of 50.67% compared to the current price of 46.46 € for Bristol-Myers Squibb.
